The Minister of Science and Innovation, Diana Morant, has stressed today that the Spanish vaccine against SARS-CoV-2 from Hipra laboratories “has a very good pace” so, if approved by the European Medicines Agency (EMA), it could start to be marketed next June and it would be “the best” on the market.
Morant recalled that Hipra is finishing the last phase of the clinical trial and, when it is finished, will transfer the results to the European regulatory agency: “If the EMA approves the vaccine, we would be ready to market it in June,” he advanced.
–
